• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Do different actors submit different evidence to alcohol advertising policy consultations?

Abstract

Introduction

This study examined the extent to which industry and non-industry actors draw from the same (vs. different) bodies of peer-reviewed evidence in submissions to alcohol advertising policy consultations.

Methods

Submissions (n = 71) to two Australian public consultations about alcohol advertising policy were classified as submitted by industry or non-industry actors. Details of cited journal articles were extracted. Articles were coded according to whether: (i) cited in industry and/or non-industry actor submission/s; (ii) findings were supported or contested by the submitter; and (iii) the article was a systematic review. The most frequently cited first authors were identified.

Results

In total, 126 articles were cited in 45 industry actor submissions and 159 articles were cited in 26 non-industry actor submissions. Only seven articles were cited by both groups. Authors cited most frequently by one actor group were rarely cited by the other group. The first author most cited by industry actors declared alcohol industry links in two articles. Industry actors cited three systematic reviews (and contested the findings); non-industry actors cited (and supported) seven systematic reviews.

Discussion and Conclusion

There was a low degree of overlap in peer-reviewed evidence cited by industry and non-industry actors in submissions to Australian alcohol advertising policy consultations. Industry actors often omitted or contested high-quality evidence. Industry actors placed greater emphasis on evidence published by one industry-linked researcher than on evidence from systematic reviews and researchers with no apparent conflicts of interest. The findings raise questions about the suitability of industry actors to participate in evidence-informed policymaking processes.

Read the full article ›

Posted in: Journal Article Abstracts on 07/16/2022 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2022 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice